Castleview Partners, LLC Prokidney Corp Ord Shs Cl A(Cy Transaction History
Castleview Partners, LLC
- $144 Million
- Q3 2024
A detailed history of Castleview Partners, LLC transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Castleview Partners, LLC holds 32,921 shares of PROK stock, worth $55,636. This represents 0.04% of its overall portfolio holdings.
Number of Shares
32,921Holding current value
$55,636% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding PROK
# of Institutions
77Shares Held
46.2MCall Options Held
505KPut Options Held
127K-
Morgan Stanley New York, NY14.3MShares$24.1 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY12.3MShares$20.9 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.22MShares$8.81 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$6.18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$3.72 Million0.0% of portfolio
About PROKIDNEY CORP ORD SHS CL A(CY
- Ticker PROK
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,540,200
- Market Cap $104M